PIGV and Elevated circulating alkaline phosphatase concentration: With the exception of hyperphosphatasia, which is known to be the result of loss of GPI-anchored complement inhibitors in blood cells [34], the proteins and cellular functions that are affected in humans with PIGV mutations are unknown.